Cargando…
Genetic predisposition in nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease whose prevalence has reached global epidemic proportions. Although the disease is relatively benign in the early stages, when severe clinical forms, including nonalcoholic steatohepatitis (NASH), cirrhosis and even hep...
Autores principales: | Sookoian, Silvia, Pirola, Carlos J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association for the Study of the Liver
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381829/ https://www.ncbi.nlm.nih.gov/pubmed/28268262 http://dx.doi.org/10.3350/cmh.2016.0109 |
Ejemplares similares
-
The lipidome in nonalcoholic fatty liver disease: actionable targets
por: Pirola, Carlos J., et al.
Publicado: (2021) -
Precision medicine in nonalcoholic fatty liver disease: New therapeutic insights from genetics and systems biology
por: Sookoian, Silvia, et al.
Publicado: (2020) -
Personalized medicine in nonalcoholic fatty liver disease
por: Pirola, Carlos J., et al.
Publicado: (2022) -
Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severity
por: Pirola, Carlos J, et al.
Publicado: (2018) -
Systems Biology Elucidates Common Pathogenic Mechanisms between Nonalcoholic and Alcoholic-Fatty Liver Disease
por: Sookoian, Silvia, et al.
Publicado: (2013)